Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."

TSX:TST - Post Discussion

TELESTA THERAPEUTICS INC > UN-Certainty?
View:
Post by thePlayer on Jun 18, 2013 11:58am

UN-Certainty?

Uncertainty - that's what keeps our stock down???  Well, at some angle

DryBones, I guess there is some meat in this logic.....  but not a lot. 

 

I would dare to say that incomparably more meat is in this idea:

 

It's a plain and almost 100% Certainty that values our stock.

 

Certainty in the fact that under leadership of Mr MacRae there iis an OVERWHELMING

possibity of wrong strategic decisions being made, completely inappropriate resources being allocated,

execution being weak and not professional, proper financial controls being "forgotten" and funds would be wasted, wrong assets would be sold for pennies (Bioniche Pharma, 20M vs 500M realized by Round Table Partners), deals would be made with not appropriate partners (EndDo) and control will be completely llost of the most critical products (example: Urocidin deal and its PIIIB Trial terms), clear promises and business objectives would be simply "forgotten" and not achieved time after time (do I really have to remind CASH BURN thing?),  countless number of self-imposed deadlines will be broken and .......  the list goes on and on and on..... and on.... 

 

Seriously, do REAL long suffering shareholders have anything to argue in this regard?  I don't think so.

Comment by DryBones on Jun 18, 2013 1:20pm
This post has been removed in accordance with Community Policy
Comment by thePlayer on Jun 18, 2013 1:42pm
DryBones, G&W clearly stated that at this point they are legally prevented from releasing their plans in detail.    Are you not buying this argument?
Comment by DryBones on Jun 18, 2013 1:57pm
This post has been removed in accordance with Community Policy
Comment by HighteawithIntrepid on Jun 18, 2013 3:23pm
player round table spent 70m on it first. 70m we did not have when we sold it. The VMC in Belleville completed can  go from 6m scrap through our 60m cost to 100, which is only 1/5 of the 500m it could be if all goes as planned. Yes the IIIB was a flawed test. suck it up. If all goes OK in Canada we can trade higher again. If you think of it as the point of maximum pessimisim it is a great ...more  
Comment by Nohandledzep on Jun 18, 2013 3:31pm
HT...I was going to sell at $2.00, but Bioncihe halted the stock on "No News" in the $1.80 range, just prior to announcing a financing at $1.45.   Since then "friends" of the company have done their best to support the share price but the efforts were futile, like most Bioniche initiatives have proven to be.    
Comment by DryBones on Jun 18, 2013 3:37pm
This post has been removed in accordance with Community Policy
Comment by peasoupfog on Jun 18, 2013 3:55pm
This post has been removed in accordance with Community Policy
Comment by peasoupfog on Jun 18, 2013 4:08pm
This post has been removed in accordance with Community Policy
Comment by DryBones on Jun 18, 2013 6:00pm
This post has been removed in accordance with Community Policy
Comment by wussy on Jun 18, 2013 7:20pm
Investment Industry Regulatory Organization of Canada - Trading Halt - Bioniche Life Sciences Inc - BNC Sep. 27, 2010 (Canada NewsWire Group) -- #ReleaseContent TABLE{ BORDER-COLLAPSE: collapse}TR.cnwUnderlinedCell TD{ BORDER-BOTTOM: #000000 1px solid}TR.cnwDoubleUnderlinedCell TD{ BORDER-BOTTOM: #000000 3px double}TR.cnwBoldUnderlinedCell TD{ BORDER-BOTTOM: #000000 3px solid}TD ...more  
Comment by thePlayer on Jun 18, 2013 8:57pm
DryBones, according to my memory your about right.  I was "lucky" enough being able to sell a few shares around $1.70-$1.80, the problem is it was small portion of my portfolio, didn't make a difference, then I bought back a bit lower, stupid me....   Other thing - your not buying G&W argument, hmm... I don't like that, they already had a little legal issue with the ...more